|
HS Code |
292812 |
| Name | Astragaloside IV |
| Chemical Formula | C41H68O14 |
| Molecular Weight | 784.97 g/mol |
| Cas Number | 84687-43-4 |
| Source | Astragalus membranaceus (plant root) |
| Appearance | White to off-white powder |
| Solubility | Slightly soluble in water, soluble in ethanol and methanol |
| Purity | ≥98% (HPLC) |
| Melting Point | 295-298°C |
| Storage Temperature | 2-8°C (refrigerated) |
| Identification Methods | HPLC, NMR, MS |
| Usage | Research on immunomodulatory and antioxidant effects |
As an accredited Astragalosideiv factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Astragaloside IV is packaged in a 100mg amber glass vial with tamper-evident seal, labeled with product details, purity, and safety information. |
| Shipping | Astragaloside IV is shipped in compliance with relevant safety regulations, securely packaged in sealed containers to prevent contamination and degradation. The shipment is typically sent at ambient temperature unless otherwise specified, with accompanying documentation such as Safety Data Sheets (SDS). Expedited shipping options ensure timely delivery to maintain product integrity. |
| Storage | Astragaloside IV should be stored at -20°C, protected from light and moisture, in a tightly sealed container. It is recommended to keep it in a desiccator or a dry, cool environment to prevent degradation. Avoid repeated freeze-thaw cycles. Proper storage ensures maximum stability and preserves the compound’s chemical integrity for laboratory and research use. |
|
Purity 98%: Astragalosideiv Purity 98% is used in pharmaceutical formulation development, where it ensures high bioavailability and consistent therapeutic outcomes. Molecular Weight 784.97 Da: Astragalosideiv Molecular Weight 784.97 Da is utilized in anti-inflammatory drug research, where precise molecular profiling facilitates targeted mechanism studies. Particle Size <50 μm: Astragalosideiv Particle Size <50 μm is incorporated in oral dosage forms, where fine dispersion increases absorption and efficacy. Stability Temperature up to 40°C: Astragalosideiv Stability Temperature up to 40°C is applied in nutraceutical product processing, where it maintains compound integrity during storage and manufacturing. Melting Point 230–232°C: Astragalosideiv Melting Point 230–232°C is used in compound isolation methods, where defined thermal properties aid in purification efficiency. Solubility in Ethanol 10 mg/mL: Astragalosideiv Solubility in Ethanol 10 mg/mL is suitable for injectable formulation design, where solubility enhances formulation flexibility and delivery potential. HPLC Assay ≥98%: Astragalosideiv HPLC Assay ≥98% is deployed in clinical trial supply production, where high assay value supports regulatory compliance and therapeutic reliability. |
Competitive Astragalosideiv prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Walk through our facility and it’s impossible not to notice how Astragaloside IV commands attention. Harvested from the hardy roots of Astragalus membranaceus, this saponin ingredient has grabbed the focus of both the supplement industry and pharmaceutical researchers— and not without reason. Astragaloside IV shows promise beyond conventional plant extract applications, reflecting the importance of reliable sourcing, careful processing, and a genuine understanding of its differences from lower-grade extracts.
Over the years, as our team has developed, extracted, and standardized this compound, we’ve learned what matters is more than just purity numbers. Anyone can flash a HPLC chromatogram and claim an Astragaloside IV content, but consistent quality begins before raw roots hit our processing line. Not every batch of astragalus yields the same content—soil quality, season, even rainfall make a difference—so direct control over sourcing sets the tone for the rest of the process.
Some of the earliest feedback we received from finished product brands came down to batch-to-batch results. Customers noticed changes in their test results or the way their formulas performed, depending on the origin and grade of the extract. So, in our operation, we dedicated time and equipment to develop a more precise extraction method. Unlike basic astragalus extracts that often contain a mix of saponins and polysaccharides, our extraction focuses specifically on isolating Astragaloside IV. This is far from a basic ethanol-based soak; careful pH adjustment, multiple filtrations, controlled drying, and sophisticated chromatography ensure that the compound we provide consistently meets the stated concentration.
We’ve settled on a few key specifications, with our Astragaloside IV models primarily offered at 98% HPLC purity. Some customers request lower titers, around 50%, to support blends or combine with whole-root fractions, but the 98% grade is the backbone. For research purposes, the market pushes for even more stringent requirements, such as foreign substance screening, exact moisture levels, and microbe thresholds. In-house, we use approaches that go beyond just the paperwork, including visual inspections— a technique old hands on our production floor insist never fails to reveal something instruments can’t spot.
Plenty of differences start with something as simple as origin. We grow and process astragalus ourselves—no middlemen between the root and the extraction vat. This isn’t just about control; it means we know exactly which farm, which planting season, and—after years in the same region—which plot gives us roots with the saponin profile our clients expect. There’s no shortcut when it comes to keeping records tight and supply chains short. Our own quality assurance team monitors pesticide residues, soil heavy metals, and harvest maturity for every delivery to our plant. Nobody wants contaminants showing up three months down the line.
Early on, we learned traceability isn’t just a buzzword but a safeguard for everyone downstream. In a market where incidents of adulteration and mislabeling are all too common, we make proof of source available for each shipment. If a regulator, customer, or research partner has a question, lot histories are ready and complete. Problems don’t get buried, and accountability keeps us focused.
Astragaloside IV’s chemical structure makes it fussy. It doesn’t tolerate sloppy extraction. During initial years, we discovered that the wrong extraction solvent or an uncontrolled pH produced a dark, sticky mess—far from the clean crystals expected. We addressed these pitfalls by automating critical steps, including temperature ramps and filtration flow rates. Humans still run regular checks; when the extract moves from column to tank, we pull quick TLC samples and digital photos to catch off-odors, colors, or separation issues before they cascade into the final product.
Over time, our staff recognized subtle indicators for potential problems—minor differences in particle texture, a hint of off-white or dullness—a warning flag that the solvent recycling system needs recalibration or a filter cake is overdue for change. Our batch notes now include these remarks for every run. Training operators to spot these early rather than relying entirely on endpoints saves us rework and saves our customers time.
It’s easy for sellers to quote numbers like “98% Astragaloside IV” but less common to walk through what these numbers mean in the real world. Practical experience tells us that customers working in pharmaceuticals, nutraceuticals, or even cosmetics look for predictability in how the powder behaves. Consistency means reliable dissolution, reproducible HPLC curves, and—perhaps most critical—clear visual inspection under white light. Our 98% grade provides sharp, nearly white powder, rarely straying to a grey edge. With lower-grade extracts, trace polysaccharides or lipids can turn the product yellowish, even at higher HPLC titers, because not all contaminants show up on the chromatogram.
Different applications demand different handling. Pharmaceutical research groups often request certificates from third-party laboratories—not because they doubt our testing, but regulators demand independent confirmation. We maintain both in-house analytical equipment and relationships with local accredited labs for cross-verification. All final lots undergo moisture content assessment, checked against established pharmacopeial limits, since too much water encourages lumping or even microbial growth, while too little overdries a product and affects its miscibility.
We ship Astragaloside IV in 1 kg vacuum-sealed foil packs for lab and pilot users, and 25 kg fiber drums with double-lining for larger orders. Our logistics team tracks real-time temperature and humidity in transit, as saponins degrade if allowed to sit too long at high heat, especially in sealed conditions. Our field experience shows products arriving with even minor package breakdown perform inconstantly in application, so packaging integrity matters as much as extraction efficiency.
Market shelves are full of astragalus products—teas, granules, tinctures, powders. Most deliver a broad-spectrum plant extract, heavy with polysaccharides, amino acids, and traces of saponins. These offer antioxidant or immune-support effects attributed historically to the plant but offer no consistency in Astragaloside IV concentration. Mass-market astragalus powders may contain as little as 0.01% Astragaloside IV, whereas ours hits at least 98% in reference standard runs. This is not just a number for marketing: customers in clinical research or sophisticated finished products need gram-level precision, which only high-purity, isolated Astragaloside IV delivers.
Another common product type, Astragalus root extracts, typically fall in the 0.5% to 2% saponin range. Their cost advantage disappears once consistent dose forms or robust pharmacological studies are required. Blending practices by third parties often mix roots from different countries, sometimes even with other legume-family plants. Our process involves only certified astragalus and maintains a single-ingredient profile, minimizing batch-to-batch variability.
Lower-tier Astragaloside IV can result from shortcuts—a single extraction cycle, minimal filtration, or excessive solvent recycling. These batches may test well on simple assays but reveal impurities or odd smells in finished applications. Over the years, we have received numerous samples from customers who were dissatisfied with competitors, who found their products contained unreacted root, residual solvents, or higher than promised ash content. Our own system double-checks for any common adulterants and ensures that the declared purity reflects the actual content through repeated HPLC and UV-VIS comparisons.
Over time, we’ve tracked feedback loops with our largest buyers. The most frequent complaint they share about the general market is unpredictable quality. Without regular, direct manufacturer oversight, ingredients drift; powder density varies, bulk flow rates shift, and taste or odor begins to turn. We have maintained our policy of direct accountability, encouraging customers to send any off-batch findings directly to our production supervisor. Any product leaving our floor comes with a release file that documents precisely the extraction dates, test results, and storage conditions from start to finish.
They’ve also told us straight: contract manufacturers and finished brand owners face problems with “spec fantasy”—numbers quoted that don’t show up in the canister. Authenticity and specification realism are so important now, especially as regulators have begun inspecting identity and trace elements in active botanical ingredients. We keep archives for each lot, so if a product lands in a third-party lab for retesting, we stand ready to provide full documentation and answers.
Much of the Astragaloside IV we produce heads straight to laboratories, where scientists continue to explore its activity. Studies have looked at possible antioxidant pathways, immune response influences, and skin benefits. Application isn’t limited to supplements. Topical applications— creams, gels, even research-grade cosmeceuticals—are appearing at a steady pace. Based on the grade and concentration, formulators can control precise dosing, which has become critical for brands positioning themselves at the upper end of the market.
We see more requests for solutions, rather than just powders. To support these, our team has worked to produce water-dispersible and carrier-bound Astragaloside IV for easier mixing in personal care and functional food applications. For powdered drink products, maintaining particle size and solubility are central—our technical team continues to collaborate with partners willing to test various blends and carriers to maximize dispersion and stability. There’s a growing interest from veterinary supplement manufacturers, and we apply the same rigorous quality controls for these special customer segments.
Quality assurance in the chemical extraction world means more than a checklist. Our on-floor teams are trained to spot issues before they reach a customer’s door. All staff responsible for final inspection have direct contact with the QC lab; any doubts in texture, color, or bulk weight prompt a halt and re-inspection. We also keep samples from every lot, allowing rapid response if queries or complaints arise. Our staff regularly cross-train on analytical instruments and review industry updates, pushing us to maintain not only compliance but practical improvements.
We’ve invested in people as much as machines. Automated systems now track production steps and monitor storage, but it’s the human element—years of sensory training and pride in the product—that makes the difference between a reliable ingredient and something that just ticks the right technical boxes. Listening to the team who handle the product daily brought us the idea to add extra steps, such as final visual inspections under raking light, or the use of new sieve sizes to improve uniform particle size. These refinements brought clear improvements in handling, dissolution, and customer satisfaction.
Good Astragaloside IV isn’t just made in the lab; it’s kept good through careful handling. Humidity, temperature, and even UV exposure can shift the quality over time. We store finished powder under nitrogen to minimize oxidation and track temperature logs in our warehouses. Each package is double-sealed and labeled with handling instructions to keep users informed. After a questionable summer shipment in early years, we started using data loggers to monitor shipping conditions. If a container sits on a dock too long, we get alerts and can advise partners to delay use or request fresh shipments.
We encourage feedback from distributors, contract manufacturers, and even research labs. Their hands-on experience—reporting clumping, discoloration or package breaches—directly feeds our process improvements. Customers are never left dealing with supply chain hiccups alone; if it reaches us, we work through it together. Maintaining an open-door policy helps resolve issues before they become problems on the market.
Over time, our team has helped resolve challenges others face in the supply of Astragaloside IV. One issue that comes up is the desire for higher solubility—particularly for beverage and topical uses. Many early attempts by market entrants resulted in powders that settled out or left residues. In our plant, we experimented with micronization techniques and tested several carriers to create a line of more dispersible Astragaloside IV. Ongoing dialogue with users led us to fine-tune the ratio of particle size to carrier content, optimizing flow and minimizing separation in complex matrices.
Another challenge: contamination or adulteration issues discovered by customers after using other sources. By maintaining a closed production loop and comprehensive in-house analytics, we support clients facing recalls or compliance audits. Many contract manufacturers brought us samples for verification after discovering their previous suppliers failed authenticity tests. In these cases, our documented history and rapid analysis enabled customers to stay operational and restore product trust.
Some newer market entrants question whether botanical purity requirements are too strict. Our view is shaped by past encounters: one missed impurity can shut down a production line, cause product recalls, or lead to long regulatory investigations. As a result, we keep our focus sharp on purity, traceability, and open communication—both internally and with every customer, big or small.
Throughout the years, we’ve learned the real test of Astragaloside IV comes down to performance in use. Cosmetics formulators want consistent texture and product clarity. Supplement manufacturers need bulk powders to flow well during high-speed encapsulation. Research customers require a product that tests identically across batches, minimizing variables in their experimental series. We find many end users return not just for the specification sheet but because of reliable support and honest problem-solving attitude.
Feedback from the field remains one of our core guiding factors. Recently, a partner developing a novel wound-care gel shared their struggle with earlier grades, where variable particle sizes altered gel viscosity and made shelf-life unpredictable. Our technical support team recommended a custom grade, with both granular analysis and tailored carrier system. The result: stable gel texture, improved absorption, and a product that passed stability testing ahead of schedule.
In another case, a pharmaceuticals group aiming for clinical trial consistency found that off-the-shelf astragalus extracts failed to deliver precise dosing. Our recommendation to switch to 98% Astragaloside IV allowed for direct, exact measurement and reproducible results in every trial. These are the successes that drive continuous improvement in our operation.
Astragaloside IV is much more than a line item in a catalog—it represents countless hours spent refining our approach and listening to the real-world needs of our customers. Every batch, every improvement, and every customer conversation shapes our next steps. We are committed to maintaining direct control over every stage, from seed selection to final quality release, because this is the only way to provide the reliability and transparency our partners demand.
We believe that Astragaloside IV produced at scale should never come at the expense of quality, safety, or openness. Our goal is to collaborate with clients—sharing data, solving problems, and building trust through consistent delivery and honest feedback. This is the ethos of responsible manufacturing, and the foundation we rely on each day as we bring Astragaloside IV from root to finished ingredient—batch after batch, partner after partner.